Connect with us:
Our Formulation Development Laboratory located in Mumbai (in line with the US-FDA requirements) is well-equipped with the technology required to conduct high-quality research activities and prototype development.
Novel Drug Delivery System (NDDS)
R&D in this area attempts to improve the efficiency with which the medicine is absorbed in the body. Novel Drug Delivery Systems (NDDS) efforts are directed towards:
Abbreviated New Drug Application (ANDA)
The filing of ANDAs received a major boost after Ipca opened its wholly-owned subsidiary in New Jersey, USA. Ipca’s research endeavours are well-supported by world-class infrastructure:
Manufacturing of generics for registration in UK/EU/South Africa/Brazil and other countries
Formulation R&D Capabilities
The group is well supported by an analytical development team, which is committed to development of analytical methodologies that provide sensitive, precise, rugged, and accurate data in minimum time. Key activities include development & validation of various analytical test procedures for Assay, Content Uniformity, Dissolution, Related Substances, Residual Solvents, other in-house test procedures and finalisation of their Specifications which will adequately evaluate desire-quality attributes.